0001644338-15-000001.txt : 20150612 0001644338-15-000001.hdr.sgml : 20150612 20150612145226 ACCESSION NUMBER: 0001644338-15-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150612 DATE AS OF CHANGE: 20150612 EFFECTIVENESS DATE: 20150612 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vigeo Therapeutics, Inc. CENTRAL INDEX KEY: 0001644338 IRS NUMBER: 461204256 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-241663 FILM NUMBER: 15928207 BUSINESS ADDRESS: STREET 1: 50 ROWES WHARF CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 617-571-6800 MAIL ADDRESS: STREET 1: 50 ROWES WHARF CITY: BOSTON STATE: MA ZIP: 02110 D 1 primary_doc.xml X0707 D LIVE 0001644338 Vigeo Therapeutics, Inc. 50 ROWES WHARF BOSTON MA MASSACHUSETTS 02110 617-571-6800 DELAWARE None None Corporation true 2011 Jason Dinges 1188 Center Street Newton Center MA MASSACHUSETTS 02459 Director Stephanie O'Brien 1188 Center Street Newton Center MA MASSACHUSETTS 02459 Director Peter B Finn c/o Rubin and Rudman LLP 50 Rowes Wharf Boston MA MASSACHUSETTS 02110 Executive Officer Director Biotechnology Decline to Disclose 06b false 2015-06-02 false true false 2500000 10000000 2500000 7500000 false 1 0 0 1875000 Executive salaries false Vigeo Therapeutics, Inc. Peter B. Finn Peter B. Finn Director 2015-06-12